CSL: Summary

CSL

Biotechnology, Healthcare, Pharmaceuticals, Biotherapies

CSL provides innovative biotherapies and vaccines that ensure patients receive the necessary treatments for serious health conditions.

CSL is a global biotechnology company that develops innovative biotherapies and influenza vaccines. It aims to save lives and assist individuals with life-threatening medical conditions through its diverse range of products.

Broad range of biotherapies for rare and serious diseases; Global leader in influenza vaccine provision; Innovative therapies for iron deficiency and nephrology; Commitment to sustainability and community support

CSL's services are most valuable in treating rare diseases, providing vaccines for public health, and addressing iron deficiency and nephrology issues.

Industry leader in plasma-derived therapies and vaccines; Strong focus on research and development with a world-class network; Commitment to sustainability and community health initiatives

CSL's main strengths include its long-standing expertise in biotechnology, a diverse product range, and a strong commitment to innovation and public health.

CSL positions itself as a leader in biotechnology, dedicated to improving health outcomes through innovative therapies and vaccines.

The target users include patients with rare and serious diseases, healthcare providers, and public health organizations.

Learn More About Our Businesses and Products

• Biotechnology

• Vaccines

• Biotherapies

• Public Health

CSL. Always Evolving for a Better World.

Professional, compassionate, innovative

CSL stands out in the biotechnology market through its extensive experience of over a century and its comprehensive portfolio that includes CSL Behring, CSL Seqirus, and CSL Vifor, addressing a wide range of health needs.

CSL's brand identity is centered around innovation, excellence in biotechnology, and a commitment to community health and sustainability.

1916-01-01